This study investigates advanced pancreatic cancer. It looks at combining irreversible electroporation (IRE) with chemotherapy treatments to see how well they work together.
The study evaluates the safety and effectiveness of using IRE with chemotherapy. Researchers want to understand how these treatments affect patients with advanced pancreatic cancer.
- Who can participate: Adults 18 years and older with stage III pancreatic cancer may join. Participants need a measurable tumor and must meet specific health criteria.
- Study details: Participants will receive chemotherapy and undergo a procedure called irreversible electroporation.